Related references
Note: Only part of the references are listed.
Letter
Rheumatology
D. N. Maritsi et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Erik Volz et al.
Summary: The study suggests a positive selection for the SARS-CoV-2 spike protein variant D614G in the UK, but no evidence of differences in COVID-19 mortality or clinical severity in patients infected with this variant. 614G is associated with higher viral load and younger age of patients compared to 614D.
Article
Microbiology
Allison J. Greaney et al.
Summary: Antibodies targeting the SARS-CoV-2 spike receptor-binding domain (RBD) are key in neutralizing antibody responses, and a deep mutational scanning method was used to assess the impact of all amino-acid mutations in the RBD on antibody binding with 10 human monoclonal antibodies. The study identified the clustered escape mutations in different surfaces of the RBD that correspond to structurally defined antibody epitopes, showing that even antibodies targeting the same surface can have distinct escape mutations.
CELL HOST & MICROBE
(2021)
Article
Multidisciplinary Sciences
Louis du Plessis et al.
Summary: The study analyzed the genetic lineage structure of the early UK COVID-19 epidemic through genomic sampling, identifying that virus lineages introduced before the national lockdown tended to be larger and more dispersed. After the lockdown, lineage importation and regional diversity decreased, while lineage elimination depended on lineage size. The research emphasizes the impact of genetic perspective on transmission dynamics for COVID-19 epidemiology and control.
Article
Public, Environmental & Occupational Health
Koen B. Pouwels et al.
Summary: This study in England found significant changes in the number of individuals testing positive for SARS-CoV-2 and risk factors for positivity over time from April to November 2020. Important risk factors for testing positive varied between the first and second waves, with age being a key driver of increased positivity rates in the second wave. Continued monitoring for SARS-CoV-2 in the community will be important for managing the COVID-19 pandemic moving forwards.
LANCET PUBLIC HEALTH
(2021)
Article
Biochemistry & Molecular Biology
Daming Zhou et al.
Summary: The race to develop vaccines against SARS-CoV-2 variants, such as B.1.1.7, B.1.351, and P.1, is ongoing as these variants have mutations in the spike protein, potentially leading to immune escape. A structure-function analysis of B.1.351 revealed tighter ACE2 binding and widespread evasion from monoclonal antibody neutralization, particularly driven by the E484K mutation.
Article
Microbiology
Allison J. Greaney et al.
Summary: The evolution of SARS-CoV-2 may impact the recognition of the virus by human antibody-mediated immunity, with mutations affecting antibody binding varying significantly among individuals and within the same individual over time. Despite this variability, mutations that greatly reduce antibody binding usually occur at specific sites in the RBD, with E484 being the most crucial. These findings can inform surveillance efforts for SARS-CoV-2 evolution in the future.
CELL HOST & MICROBE
(2021)
Article
Biochemistry & Molecular Biology
Houriiyah Tegally et al.
Summary: The study identified 16 new lineages of SARS-CoV-2 in South Africa between March and August 2020, with unique mutations not found elsewhere. Three lineages (B.1.1.54, B.1.1.56, and C.1) dominated during the country's first wave, accounting for approximately 42% of all infections. The C.1 lineage, with 16 nucleotide mutations including the D614G spike protein change, became the most geographically widespread by August 2020. Genomic surveillance played a crucial role in identifying the 501Y.V2 variant in South Africa in December 2020.
Article
Virology
Lucy van Dorp et al.
Summary: The unprecedented international efforts to sequence SARS-CoV-2 genomes have led to rapid characterization of the virus and successful vaccine development programs. Global genomic resources provide a good understanding of the pandemic and support monitoring of viral diversity, while continued genomic surveillance is crucial for informing the timing of vaccine updates. Room for improvement lies in less heterogeneous global surveillance and tools to rapidly identify concerning viral lineages.
CURRENT OPINION IN VIROLOGY
(2021)
Article
Medicine, General & Internal
Joel Hellewell et al.
Summary: The study used Bayesian statistical model to analyze PCR testing data of UK healthcare workers, finding that the detection probability peaked at 77% 4 days after infection but decreased to 50% by 10 days. Testing every other day was estimated to detect 57% of symptomatic cases before onset and 94% of asymptomatic cases within 7 days if results are returned promptly.
Article
Biochemistry & Molecular Biology
Nicole L. Washington et al.
Summary: The highly transmissible B.1.1.7 variant of SARS-CoV-2, first identified in the United Kingdom, has been spreading in the United States with multiple introductions as early as late November 2020. The variant shows a logistic growth rate with roughly weekly doubling and increased transmission, requiring immediate action to minimize COVID-19 morbidity and mortality.
Article
Multidisciplinary Sciences
Erik Volz et al.
Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.
Article
Genetics & Heredity
Yatish Turakhia et al.
Summary: UShER is an efficient method that aids in real-time analysis of viral evolution during the COVID-19 pandemic by facilitating the addition of new SARS-CoV-2 genome sequences onto the existing phylogeny. The unprecedented accumulation of viral genome sequences is leading to a new era of 'genomic contact tracing' using viral genomes to trace local transmission dynamics. UShER addresses the challenge of placing new sequences onto the already large viral phylogeny, thus improving the speed of phylogenetic placement and data visualization for real-time contact tracing.
Article
Biochemistry & Molecular Biology
Delphine Planas et al.
Summary: The ability of convalescent sera from individuals with coronavirus disease 2019 and those vaccinated with BNT162b2 to neutralize SARS-CoV-2 variants B1.1.7 and B.1.351 decreases, but increases after two vaccine doses. The study found that the B.1.1.7 and B.1.351 variants may have acquired partial resistance to neutralizing antibodies generated by natural infection or vaccination, particularly in individuals with low antibody levels. This suggests that the B.1.351 variant may pose a greater risk of infection in immunized individuals.
Article
Multidisciplinary Sciences
Nuno R. Faria et al.
Summary: A new variant of concern, P.1, with 17 mutations including three spike protein mutations associated with increased binding to human ACE2 receptors, emerged in Manaus, Brazil between November 2020 and January 2021. Molecular analysis suggests P.1 may be 1.7- to 2.4-fold more transmissible and that previous infection may provide 54 to 79% protection against P.1 infection compared to other lineages. Enhanced global genomic surveillance of such variants is crucial for pandemic response.
Article
Infectious Diseases
David Hodgson et al.
Summary: Achieving herd immunity against SARS-CoV-2 through vaccination requires high vaccine effectiveness and coverage, especially in the presence of highly transmissible variants and populations with low levels of pre-existing immunity.
Letter
Medicine, General & Internal
Emma C. Wall et al.
Article
Multidisciplinary Sciences
Emma B. Hodcroft et al.
Summary: A variant of SARS-CoV-2, 20E (EU1), was identified in Spain in early summer 2020 and later spread across Europe. Despite not showing increased transmissibility, the variant's success can be attributed to rising incidence in Spain, resumption of travel, and lack of effective screening and containment measures. Travel played a significant role in introducing the variant multiple times to European countries during the summer, undermining local efforts to prevent SARS-CoV-2 infection.
Article
Multidisciplinary Sciences
Moritz U. G. Kraemer et al.
Summary: Understanding the spatial invasion dynamics of the B.1.1.7 lineage, researchers found a multistage process with early growth rates linked to human mobility and asymmetric lineage export from dominant source locations. Additionally, they explored how the spread of B.1.1.7 was influenced by nonpharmaceutical interventions and spatial variation in previous attack rates. The study emphasizes the importance of considering behavioral and epidemiological contexts in accurately interpreting the growth rates of emerging variants of concern.
Article
Microbiology
Jiri Zahradnik et al.
Summary: In vitro evolution of the SARS-CoV-2 spike protein receptor-binding domain successfully generated a high-affinity variant effective in inhibiting virus infection. Mutations present in more transmissible viruses were preferentially selected, and increased affinity to ACE2 was positively correlated with the incidence of RBD mutations in the population. The study also identified mutations with potential higher infectivity, and the high-affinity RBD variant showed efficacy in inhibiting infection in vitro and reducing clinical disease in a hamster model of SARS-CoV-2 challenge.
NATURE MICROBIOLOGY
(2021)
Article
Infectious Diseases
Qifang Bi et al.
LANCET INFECTIOUS DISEASES
(2020)
Article
Biochemistry & Molecular Biology
Tyler N. Starr et al.
Article
Microbiology
Andrew Rambaut et al.
NATURE MICROBIOLOGY
(2020)
Article
Multidisciplinary Sciences
Tom Britton et al.
Article
Medicine, General & Internal
Sebastian Funk et al.
Article
Biochemical Research Methods
James Hadfield et al.
Article
Virology
Pavel Sagulenko et al.
Article
Genetics & Heredity
Nicola De Maio et al.
Article
Public, Environmental & Occupational Health
Anne Cori et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY
(2013)
Article
Biochemistry & Molecular Biology
Mandev S. Gill et al.
MOLECULAR BIOLOGY AND EVOLUTION
(2013)
Article
Multidisciplinary Sciences
Morgan N. Price et al.
Article
Biochemical Research Methods
Philippe Lemey et al.
PLOS COMPUTATIONAL BIOLOGY
(2009)
